The Rise Fund
Active
San Francisco, United States
64
106M
45
8.00
20
0.30
5
- Areas of investment
Summary
The Rise Fund appeared to be the VC, which was created in 2016.
The top activity for fund was in 2018. The increased amount of exits for fund were in 2019. The fund is generally included in 7-12 deals every year. The usual things for fund are deals in the range of 50 - 100 millions dollars. Considering the real fund results, this VC is 50 percentage points more often commits exit comparing to other organizations. Opposing the other organizations, this The Rise Fund works on 24 percentage points less the average amount of lead investments. The average startup value when the investment from The Rise Fund is more than 1 billion dollars.
The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight C3 IoT, EVERFI, Zipline. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are FinTech, Therapeutics.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the The Rise Fund, startups are often financed by e.ventures, TomorrowVentures, Sound Ventures. The meaningful sponsors for the fund in investment in the same round are TPG Growth, Velocity Capital & Progression Africa, Endeavor Catalyst. In the next rounds fund is usually obtained by e.ventures, Warburg Pincus, Torch Capital.
Investor highlights
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 64
- Lead investments
- 20
- Exits
- 5
- Rounds per year
- 8.00
- Follow on index
- 0.30
- Investments by industry
- Financial Services (14)
- Health Care (12)
- FinTech (10)
- Therapeutics (9)
- Education (8) Show 82 more
- Investments by region
-
- United States (44)
- China (3)
- United Kingdom (1)
- Israel (2)
- Canada (3) Show 6 more
- Peak activity year
- 2018
- Number of Unicorns
- 6
- Number of Decacorns
- 6
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 344M
- Group Appearance index
- 0.84
- Avg. company exit year
- 6
- Avg. multiplicator
- 4.24
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Ceribell | 25 Sep 2018 | Biotechnology, Health Care, Health Diagnostics, Medical Device | Early Stage Venture | 35M | United States, California, Mountain View |
| Letao | 01 Dec 2010 | E-Commerce, Internet, Shoes | Late Stage Venture | 32M | Beijing, Fengtai District, China |
| Sionna Therapeutics | 06 Mar 2024 | Health Care, Genetics, Medical, Pharmaceutical, Therapeutics | Late Stage Venture | 182M | United States, Massachusetts, Natick |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.